These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28496303)

  • 1. Development of a potent invigorator of immune responses endowed with both preventive and therapeutic properties.
    Talwar GP; Gupta JC; Mustafa AS; Kar HK; Katoch K; Parida SK; Reddi PP; Ahmed N; Saini V; Gupta S
    Biologics; 2017; 11():55-63. PubMed ID: 28496303
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Dogra S; Jain S; Sharma A; Chhabra S; Narang T
    Indian Dermatol Online J; 2023; 14(6):753-761. PubMed ID: 38099011
    [No Abstract]   [Full Text] [Related]  

  • 3. Mycobacterium indicus pranii is a potent immunomodulator for a recombinant vaccine against human chorionic gonadotropin.
    Purswani S; Talwar GP; Vohra R; Pal R; Panda AK; Lohiya NK; Gupta JC
    J Reprod Immunol; 2011 Sep; 91(1-2):24-30. PubMed ID: 21885129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generalized granulomatous dermatitis following Mycobacterium w (Mw) immunotherapy in lepromatous leprosy.
    Khullar G; Narang T; Nahar Saikia U; Dogra S
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27891733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell wall fraction of Mycobacterium indicus pranii shows potential Th1 adjuvant activity.
    Saqib M; Khatri R; Singh B; Gupta A; Bhaskar S
    Int Immunopharmacol; 2019 May; 70():408-416. PubMed ID: 30856391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of Mw as a prophylactic vaccine against pulmonary tuberculosis.
    Katoch K; Singh P; Adhikari T; Benara SK; Singh HB; Chauhan DS; Sharma VD; Lavania M; Sachan AS; Katoch VM
    Vaccine; 2008 Feb; 26(9):1228-34. PubMed ID: 18243430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intralesional immunotherapy with killed Mycobacterium indicus pranii vaccine for the treatment of extensive cutaneous warts.
    Singh S; Chouhan K; Gupta S
    Indian J Dermatol Venereol Leprol; 2014; 80(6):509-14. PubMed ID: 25382507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Making of a vaccine preventing pregnancy without impairment of ovulation and derangement of menstrual regularity and bleeding profiles.
    Talwar GP
    Contraception; 2013 Mar; 87(3):280-7. PubMed ID: 23040138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy induction by Mycobacterium indicus pranii promotes Mycobacterium tuberculosis clearance from RAW 264.7 macrophages.
    Singh B; Saqib M; Gupta A; Kumar P; Bhaskar S
    PLoS One; 2017; 12(12):e0189606. PubMed ID: 29236768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapeutic efficacy of Mycobacterium indicus pranii in eliciting anti-tumor T cell responses: critical roles of IFNγ.
    Rakshit S; Ponnusamy M; Papanna S; Saha B; Ahmed A; Nandi D
    Int J Cancer; 2012 Feb; 130(4):865-75. PubMed ID: 21455983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-releasing hormone/human chorionic gonadotropin beta based recombinant antibodies and vaccines.
    Talwar GP; Vyas HK; Purswani S; Gupta JC
    J Reprod Immunol; 2009 Dec; 83(1-2):158-63. PubMed ID: 19854518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoarabinomannan from Mycobacterium indicus pranii shows immunostimulatory activity and induces autophagy in macrophages.
    Singh B; Saqib M; Chakraborty A; Bhaskar S
    PLoS One; 2019; 14(10):e0224239. PubMed ID: 31648257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a highly immunogenic recombinant candidate vaccine against human chorionic gonadotropin.
    Purswani S; Talwar GP
    Vaccine; 2011 Mar; 29(12):2341-8. PubMed ID: 21272600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CXCL10 (IP-10) and CXCL11 (I-TAC) chemokines during Mycobacterium tuberculosis infection and immunoprophylaxis with Mycobacterium indicus pranii (Mw) in guinea pig.
    Rawat KD; Chahar M; Reddy PV; Gupta P; Shrivastava N; Gupta UD; Natrajan M; Katoch VM; Katoch K; Chauhan DS
    Infect Genet Evol; 2013 Jan; 13():11-7. PubMed ID: 23107775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in development of a contraceptive vaccine against human chorionic gonadotropin.
    Talwar GP; Gupta JC; Rulli SB; Sharma RS; Nand KN; Bandivdekar AH; Atrey N; Singh P
    Expert Opin Biol Ther; 2015; 15(8):1183-90. PubMed ID: 26160491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene cooption in mycobacteria and search for virulence attributes: comparative proteomic analyses of Mycobacterium tuberculosis, Mycobacterium indicus pranii and other mycobacteria.
    Singh Y; Kohli S; Sowpati DT; Rahman SA; Tyagi AK; Hasnain SE
    Int J Med Microbiol; 2014 Jul; 304(5-6):742-8. PubMed ID: 24951307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium indicus pranii (MIP) mediated host protective intracellular mechanisms against tuberculosis infection: Involvement of TLR-4 mediated signaling.
    Das S; Chowdhury BP; Goswami A; Parveen S; Jawed J; Pal N; Majumdar S
    Tuberculosis (Edinb); 2016 Dec; 101():201-209. PubMed ID: 27865392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium indicus pranii as a booster vaccine enhances BCG induced immunity and confers higher protection in animal models of tuberculosis.
    Saqib M; Khatri R; Singh B; Gupta A; Kumar A; Bhaskar S
    Tuberculosis (Edinb); 2016 Dec; 101():164-173. PubMed ID: 27865389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines and passive immunological approaches for the control of fertility and hormone-dependent cancers.
    Talwar GP
    Immunol Rev; 1999 Oct; 171():173-92. PubMed ID: 10582171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunotherapeutic vaccine for multibacillary leprosy.
    Talwar GP
    Int Rev Immunol; 1999; 18(3):229-49. PubMed ID: 10614726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.